Terms ending in 2038
Every in-force patent on Actelion Pharmaceuticals Ltd's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D974,921 | Pharmaceutical Package In force · High confidence | Vanda Pharmaceuticals Inc. | In force | High confidence | |
| US 10,899,695 | A Novel Process for the Synthesis of 1-ARYL-1-Trifluoromethylcyclopropanes In force · High confidence | Idorsia Pharmaceuticals Ltd. | In force | High confidence | |
| US 10,919,881 | Crystalline Forms of a 4-Pyrimidinesulfamide Derivative Aprocitentan In force · High confidence | Idorsia Pharmaceuticals Ltd. | In force | High confidence | |
| US 12,297,189 | Crystalline Forms of a 4-Pyrimidinesulfamide Derivative Aprocitentan In force · Low confidence | Idorsia Pharmaceuticals Ltd. | In force | Low confidence | |
| US 11,787,782 | Combinations of a 4-Pyrimidinesulfamide Derivative with Active Ingredients for the Treatment of Endothelin Related Diseases In force · Medium confidence | Idorsia Pharmaceuticals Ltd. | In force | Medium confidence | |
| US 11,179,390 | Subcutaneous Administration of a P2Y12 Receptor Antagonist In force · High confidence | Viatris Asia Pacific Pte. Ltd. | In force | High confidence | |
| US 11,713,297 | Crystalline Form of N-Butyldeoxygalactonojirimycin In force · High confidence | Idorsia Pharmaceuticals Ltd. | In force | High confidence | |
| US 11,124,488 | Preparation of 2-([1,2,3]TRIAZOL-2-YL)-BENZOIC Acid Derivatives In force · High confidence | Idorsia Pharmaceuticals Ltd. | In force | High confidence | |
| US 11,723,896 | Pharmaceutical Combination Comprising Ponesimod In force · High confidence | Vanda Pharmaceuticals Inc. | In force | High confidence | |
| US 11,446,298 | Pyrimidine Derivatives In force · High confidence | Idorsia Pharmaceuticals Ltd. | In force | High confidence | |
| 6 more term ends in 2038 · Pro | |||||
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
1 of these is in force and held by Actelion Pharmaceuticals Ltd.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.